Theory and application of TTFields in newly diagnosed glioblastoma
CNS Neuroscience & Therapeutics · 2024-03 · 30 (3)
DOI: 10.1111/cns.14563 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift CNS Neuroscience & Therapeutics, online erschienen am 13.03.2024. Verfasst von Ao Yu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiotherapy, Liaoning Cancer Hospital & Institute, Cancer Hospital of China Medical University, Cancer Hospital of Dalian University o…. Hauptthemen laut MEDLINE: Glioblastoma, Glioma, Electric Stimulation Therapy, Brain Neoplasms. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 76 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Liaoning Province.
Abstract (Originalsprache)
Background
Glioblastoma is the most common primary malignant brain tumor in adults. TTFields is a therapy that use intermediate‐frequency and low‐intensity alternating electric fields to treat tumors. For patients with ndGBM, the addition of TTFields after the concurrent chemoradiotherapy phase of the Stupp regimen can improve prognosis. However, TTFields still has the potential to further prolong the survival of ndGBM patients.
Aim
By summarizing the mechanism and application status of TTFields in the treatment of ndGBM, the application prospect of TTFields in ndbm treatment is prospected.
Methods
We review the recent literature and included 76 articles to summarize the mechanism of TTfields in the treatment of ndGBM. The current clinical application status and potential health benefits of TTFields in the treatment of ndGBM are also discussed.
Results
TTFields can interfere with tumor cell mitosis, lead to tumor cell apoptosis and increased autophagy, hinder DNA damage repair, induce ICD, activate tumor immune microenvironment, reduce cancer cell metastasis and invasion, and increase BBB permeability. TTFields combines with chemoradiotherapy has made progress, its optimal application time is being explored and the problems that need to be considered when retaining the electrode patches for radiotherapy are further discussed. TTFields shows potential in combination with immunotherapy, antimitotic agents, and PARP inhibitors, as well as in patients with subtentorial gliomas.
Conclusion
This review summarizes mechanisms of TTFields in the treatment of ndGBM, and describes the current clinical application of TTFields in ndGBM. Through the understanding of its principle and application status, we believe that TTFields still has the potential to further prolong the survival of ndGBM patients. Thus,research is still needed to explore new ways to combine TTFields with other therapies and optimize the use of TTFields to realize its full potential in ndGBM patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Radiotherapy, Liaoning Cancer Hospital & Institute, Cancer Hospital of China Medical University, Cancer Hospital of Dalian University of Technology, Shenyang, China.
- School of Graduate, China Medical University, Shenyang, China.
- Department of Oncology, Shengjing Hospital of China Medical University, Shenyang, China.
ORCID-Profile: Ao Yu
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Liaoning Province
Zitieren
APA
Yu, A., Zeng, J., Yu, J., Cao, S., & Li, A. (2024). Theory and application of TTFields in newly diagnosed glioblastoma. CNS Neuroscience & Therapeutics, 30(3). https://doi.org/10.1111/cns.14563
Vancouver
Yu A, Zeng J, Yu J, Cao S, Li A. Theory and application of TTFields in newly diagnosed glioblastoma. CNS Neuroscience & Therapeutics. 2024;30(3). doi:10.1111/cns.14563
BibTeX
@article{Yu2024,
author = {Yu, Ao and Zeng, Juan and Yu, Jinhui and Cao, Shuo and Li, Ailin},
title = {Theory and application of TTFields in newly diagnosed glioblastoma},
journal = {CNS Neuroscience & Therapeutics},
year = {2024},
volume = {30},
number = {3},
doi = {10.1111/cns.14563}
}
EUVIMED